DFNA5 Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP6842a
Background:
Hearing impairment is a heterogeneous condition with over 40 loci described. DFNA5 is expressed in fetal cochlea, however, its function is not known.
Other Names:
Non-syndromic hearing impairment protein 5, Inversely correlated with estrogen receptor expression 1, ICERE-1, DFNA5, ICERE1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6842a was selected from the N-term region of human DFNA5. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: GSDME {ECO:0000303|PubMed:28459430, ECO:0000312|HGNC:HGNC:2810}
Gene ID: 1687
Primary Accession: O60443
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Hearing impairment is a heterogeneous condition with over 40 loci described. DFNA5 is expressed in fetal cochlea, however, its function is not known.
Other Names:
Non-syndromic hearing impairment protein 5, Inversely correlated with estrogen receptor expression 1, ICERE-1, DFNA5, ICERE1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6842a was selected from the N-term region of human DFNA5. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: GSDME {ECO:0000303|PubMed:28459430, ECO:0000312|HGNC:HGNC:2810}
Gene ID: 1687
Primary Accession: O60443
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review